These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8176722)

  • 1. Anti-Candida activity of murine bronchoalveolar lavage fluid.
    Samaranayake LP; Tobgi RS; MacFarlane TW
    J Med Microbiol; 1994 May; 40(5):350-7. PubMed ID: 8176722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidacidal factors in murine bronchoalveolar lavage fluid.
    Nugent KM; Fick RB
    Infect Immun; 1987 Mar; 55(3):541-6. PubMed ID: 3818084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Candida species to lactoferrin.
    Xu YY; Samaranayake YH; Samaranayake LP; Nikawa H
    Med Mycol; 1999 Feb; 37(1):35-41. PubMed ID: 10200932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Candida antigen in bronchoalveolar lavage fluid.
    Ness MJ; Rennard SI; Vaughn WP; Ghafouri MA; Linder JA
    Acta Cytol; 1988; 32(3):347-52. PubMed ID: 3376701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
    Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
    J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
    Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
    J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
    Novikova N; Rodrigues A; Mårdh PA
    Infect Dis Obstet Gynecol; 2002; 10(2):89-92. PubMed ID: 12530485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.